IMU 5.41% 3.9¢ imugene limited

Ann: Imugene doses first patient in HER-Vaxx phase 2 trial, page-21

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,452 Posts.
    lightbulb Created with Sketch. 314
    The Ph2 trial is open label, so no need for placebo. Everyone involved knows who’s getting what with no blinding. Placebo is probably deemed to be very unethical in this situation with the results we have already. This is very good...something you’d expect in a Ph3, but a highly unmet clinical need & safety data is good.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
0.002(5.41%)
Mkt cap ! $386.7M
Open High Low Value Volume
3.6¢ 4.0¢ 3.5¢ $1.163M 31.27M

Buyers (Bids)

No. Vol. Price($)
6 2275218 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 196677 3
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.